PEOPLE - Rubicon Medical (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Medical device and product developer and manufacturer Rubicon Medical (Salt Lake City, Utah), has appointed Ebberhard Grube as the principal investigator for the company's European embolic protection CE Mark study in coronary bypass grafts. Dr Grube currently serves as a consulting professor in the division of cardiovascular medicine at the Stanford University school of medicine.